IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nagaraju R. Arakotaram who started this subject	6/17/2001 10:10:43 PM
From: gemini67	Read Replies (1) of 1510

BETTER RESULTS THAN REMUNE IN PRE-CLINICAL!! Viral Genetics is another California company that is making very significant strides with a patented, HIV immune therapy, that relies on injections which apparently stimulate the immune system. The three pre-clinical trials conducted to date have had remarkable results, showing substantial decreases in the viral loads of HIV and fulminant AIDS patients, including those that had become non responders the AZT cocktail. VG's story and product is just beginning to be heard, but it will get loud. The company is actually not yet public, but is expected to complete a merger with HTHV:OTCBB this coming week. Here is the link to that SEC filing: sec.gov I will continue to watch IMNR and TMGU in these exciting times and for those of you that have an avid interest in this part of the biotech sector, keep an eye on the Viral Genetics story.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next